CRIS Current Research Information System

GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.444
EU - Europa 6.627
AS - Asia 6.497
AF - Africa 389
Continente sconosciuto - Info sul continente non disponibili 343
SA - Sud America 336
OC - Oceania 12
Totale 22.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.337
VN - Vietnam 2.111
IT - Italia 1.889
SG - Singapore 1.691
CN - Cina 1.514
GB - Regno Unito 1.410
DE - Germania 774
SE - Svezia 702
HK - Hong Kong 384
FR - Francia 382
UA - Ucraina 363
RU - Federazione Russa 298
IN - India 296
BR - Brasile 237
IE - Irlanda 214
NL - Olanda 158
ZA - Sudafrica 124
JP - Giappone 115
EE - Estonia 111
FI - Finlandia 90
TG - Togo 88
CA - Canada 69
CI - Costa d'Avorio 62
BG - Bulgaria 61
JO - Giordania 60
PH - Filippine 55
NG - Nigeria 47
AR - Argentina 45
BD - Bangladesh 43
KR - Corea 43
SC - Seychelles 36
CH - Svizzera 35
BE - Belgio 32
TH - Thailandia 26
AT - Austria 24
IR - Iran 24
PL - Polonia 21
MX - Messico 17
PK - Pakistan 17
TW - Taiwan 16
IQ - Iraq 15
TR - Turchia 15
ID - Indonesia 14
ES - Italia 13
AU - Australia 12
EC - Ecuador 12
GR - Grecia 12
LB - Libano 12
CL - Cile 11
UZ - Uzbekistan 11
CO - Colombia 10
MA - Marocco 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
EU - Europa 7
KE - Kenya 7
PY - Paraguay 7
RO - Romania 7
LT - Lituania 6
UY - Uruguay 6
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
PE - Perù 4
PT - Portogallo 4
VE - Venezuela 4
OM - Oman 3
SV - El Salvador 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MY - Malesia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 22.306
Salva come PNG Salva come JPEG
Città #
Southend 1.235
Singapore 1.170
Ashburn 904
Fairfield 838
San Jose 524
Chandler 483
Woodbridge 472
Ho Chi Minh City 443
Wilmington 434
Houston 413
Seattle 405
Hanoi 396
Hong Kong 368
Santa Clara 323
Cambridge 297
Dong Ket 292
Princeton 290
Ann Arbor 264
Jacksonville 226
Beijing 218
Dublin 213
Boardman 179
Milan 178
Padova 150
Nanjing 149
Bologna 140
Lauterbourg 132
Westminster 132
Rome 119
Council Bluffs 110
New York 109
Tokyo 104
Berlin 97
Los Angeles 94
Lomé 88
Helsinki 81
Bremen 77
Buffalo 76
Shenyang 73
Jinan 72
Hefei 68
Dallas 67
Haiphong 65
Turin 63
Abidjan 62
Saint Petersburg 62
Amman 60
Sofia 60
Da Nang 55
Changsha 53
Abeokuta 45
Munich 45
San Diego 45
Medford 44
Frankfurt am Main 43
Florence 42
Guangzhou 42
Zhengzhou 42
Hebei 40
Nanchang 40
Mülheim 39
Naples 37
Tianjin 36
Redondo Beach 35
Shanghai 33
São Paulo 33
Dearborn 31
Verona 31
Jiaxing 30
Brussels 29
Bari 26
London 25
Mahé 23
Bern 22
Biên Hòa 22
Falkenstein 22
Quận Bình Thạnh 21
Redwood City 21
Hangzhou 20
Hải Dương 20
Ningbo 20
Toronto 20
Chicago 19
Des Moines 18
Falls Church 18
Thái Nguyên 18
Can Tho 17
Olalla 17
Seoul 17
Yubileyny 17
Bắc Ninh 16
Taizhou 16
Johannesburg 15
The Dalles 15
Catania 14
Nuremberg 14
Trento 14
Vienna 14
Vinh 14
Ancona 13
Totale 14.293
Salva come PNG Salva come JPEG
Nome #
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 1.381
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 319
Sicurezza dell'utilizzo delle statine nel paziente trapiantato di cuore:16 anni di esperienza clinica. 318
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 310
First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation 281
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 252
Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: A meta-analysis 247
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 246
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 241
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 230
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 222
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 211
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 208
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 207
Electrocardiographic remodeling during cardiac resynchronization therapy 204
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 204
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 201
Age and heart transplantation: results from a heart failure management unit. 198
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 196
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 195
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 194
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 193
Cardiac transplantation from a carbon monoxide intoxicated donor. 193
Post-operative pleural effusion in a heart transplant recipient: A singlecase study of physiotherapy treatment 192
Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. 191
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 191
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 189
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 187
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 186
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 186
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 186
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 186
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 184
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 181
Implantation of cardioverter-defibrillator: Effects on shoulder function. 181
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 180
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 180
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 179
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 179
Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation 176
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 175
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 175
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 173
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 172
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 171
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 169
Efficacia del trattamento a lungo termine con statine nel paziente trapiantato di cuore. 168
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 167
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 165
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 164
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 164
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 163
Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study 163
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 162
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 162
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 162
Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets 162
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 161
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 161
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 159
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 157
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy. 157
EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 156
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 154
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 154
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 153
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 152
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 152
Left Atrial Size is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets: Results from a Large International Multicenter Study. 152
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 151
Comparative effectiveness of disease-modifying-drugs in elderly patients after incident hospitalization for heart failure 150
RotaFlow and CentriMag Extracorporeal Membrane Oxygenation Support Systems as Treatment Strategies for Refractory Cardiogenic Shock 149
Heart transplantation in hypertrophic cardiomyopathy. 148
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 148
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 148
Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: A multicenter analysis 147
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 146
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 146
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it? 146
Cardiac resynchronization by pacing: an electrical treatment of heart failure 146
The risk of right ventricular failure with current continuous-flow left ventricular assist devices 145
Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study 144
Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. 143
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 142
Prevalence of substance-related disorders in heart transplantation candidates 142
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 142
Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. 141
Atrial fibrillation, vascular phenotype, APOE genotype and Alzheimer's Disease: a perspective cohort study 141
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 140
Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International Study 140
Management of asymptomatic mitral regurgitation. 139
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 139
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 139
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 138
Evaluation of postural disorders in patients pre and post heart transplant. 136
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 136
Quantitation of mitral regurgitation 135
Walking in intensive care unit while recovering from heart transplantation 134
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 134
Totale 18.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.308 0 112 169 316 224 138 59 157 110 191 428 404
2022/20232.642 258 360 157 340 205 208 77 136 458 101 210 132
2023/2024819 65 122 42 96 58 167 38 34 31 67 55 44
2024/20252.765 153 429 233 219 504 134 156 106 48 200 68 515
2025/20266.294 823 442 494 364 720 352 559 403 1.298 457 202 180
2026/2027181 92 89 0 0 0 0 0 0 0 0 0 0
Totale 22.648